Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 4Papillomavirus Infections 3Inflammation 2Frailty 2Uterine Cervical Dysplasia 1Triple Negative Breast Neoplasms 1Squamous Intraepithelial Lesions 1Small Cell Lung Carcinoma 1Radiodermatitis 1Prostatic Neoplasms 1Papilloma 1Low-Grade Intraepithelial Neoplasia of Cervix 1Liver Neoplasms 1Liver Cirrhosis 1Fibrosis 1Esophageal Neoplasms 1Deglutition Disorders 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Atypical Squamous Cells of the Cervix 1

Interventions

epigallocatechin gallate 1Vitamin B 12 1Sugars 1Radiotherapy, Intensity-Modulated 1Propranolol 1Papanicolaou Test 1Narrow Band Imaging 1Microsurgery 1Maltose 1Lasers, Gas 1Lasers, Dye 1Laser Therapy 1Interferon-alpha 1Hyaluronic Acid 1Human Papillomavirus DNA Tests 1Folic Acid 1Colposcopy 1Cisplatin 1Cidofovir 1Celecoxib 1Carboplatin 1Bevacizumab 13,3'-diindolylmethane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Papilloma × epigallocatechin gallate × Clear all
NCT05625308 2022-12-22

Effect of Natural Compounds on the Severity of HPV-induced Cervical Lesions

Lo.Li.Pharma s.r.l

Phase NA Completed
40 enrolled

Papilloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡